Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease

Purinergic Signalling

Volumn 8, Issue 4, 2012, Pages 753-762

  Souza, Viviane do Carmo Gonçalves ^a   Schlemmer, Karine B ^a   Noal, Cristiano B ^a   Jaques, Jeandre A S ^a   Bagatini, Margarete D ^a   Pimentel, Victor C ^a   Carli, Luiz Felipe D ^a   Leal, Cláudio A M ^a   Fleck, Juliana ^a   Moretto, Maria B ^a   Schetinger, Maria R C ^a   Leal, Daniela B R ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Adenosine; Adenosine triphosphate; Chagas disease; Platelet aggregation; Trypanosoma cruzi

Indexed keywords

ECTO 5' NUCLEOTIDASE; ECTO ADENOSINE DEAMINASE; ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; ECTO NUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE; ECTOENZYME; ENZYME; LACTATE DEHYDROGENASE; PURINERGIC RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; FEMALE; HEMOSTASIS; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PROTEIN DETERMINATION; PROTHROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATE; BLOOD PLATELETS; CHAGAS DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET COUNT;

EID: 84867882275     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-012-9322-7     Document Type: Article

References (55)

1. Rossi MA, Bestetti RB (1995) Hipótese unificada sobre a patogênese da cardiopatia chagásica crônica. Implicações terapêuticas. Arq Bras Cardiol 64: 255-260.
2. Prata A (2001) Clinical and epidemiological aspects of Chagas' disease. Lancet Infect Dis 1: 92-100.
3. Prata A (1959) Prognóstico e complicações da doença de Chagas. Rev Goiana Med 5: 87-96.
4. Gonçalves JG, Dias Silva VJ, Calzada Borges MC, Prata A, Correia D (2010) Mortality indicators among chronic Chagas patients living in an endemic area. Int J Cardiol 143: 235-242.
5. Rossi MA (1990) Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am Heart J 120: 233-236.
6. Prata A (1994) Chagas' disease. Infect Dis Clin North Am 8: 61-76.
7. Jr Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, Hasslocher-Moreno A, Sousa AS, Scanavacca MI (2006) Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 355: 799-808.
8. Marcus AJ, Broekman MJ, Drosopoulos JH, Pinsky DJ, Islam N, Maliszewsk CR (2001) Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular disease. Ital Heart J 2: 824-830.
9. Birk AV, Broekman MJ, Gladek EM, Robertson HD, Drosopoulos JH, Marcus AJ, Szeto HH (2002) Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 140: 166-175.
10. Ralevic V, Burnstock G (2003) Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 16: 133-140.
11. Atkinson B, Dwyer K, Enjyoji K, Robson SC (2006) Ecto-nucleotidases of the cd-39/ntpdase family modulated platelet activation on thrombous formation: potential as therapeutic targets. Blood Cells Mol Dis 36: 217-222.
12. Clifford EE, Parker K, Humphreys BD, Kertesy SB, Dubyak GR (1998) The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. Blood 91: 3172-3181.
13. Léon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C (1997) The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403: 26-30.
14. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D et al (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (Lond) 409: 202-207.
15. Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedeberg Arch Pharmacol 362: 299-309.
16. Yang D, Chen H, Koupenova M, Carroll SH, Eliades A, Freedman JE, Toselli P, Ravid K (2010) A new role for the A2b adenosine receptor in regulating platelet function. J Thromb Haemost 8: 817-827.
17. Johnston-Cox HA, Yang D, Ravid K (2011) Physiological implications of adenosine receptor-mediated platelet aggregation. J Cell Physiol 226: 46-51.
18. Pilla C, Emanuelli T, Frassetto SS, Battastini AMO, Dias RD, Sarkis JJF (1996) ATP diphosphohydrolase activity (Apyrase, EC 3. 6. 1. 5.) in human blood platelets. Platelets 7: 225-230.
19. Lunkes IG, Lunkes D, Stefanello F, Morch A, Morch MV, Mazzantti MC, Schetinger MCR (2003) Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 109: 189-194.
20. Spanevello RM, Mazzanti CM, Bagatini M, Correa M, Schmatz R, Stefanello N, Thomé G, Morsch VM, Becker L, Bellé L, de Oliveira L, Schetinger MR (2010) Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients. J Neurol 257: 24-30.
21. Becker LV, Rosa CS, Souza VCG, Bagatini MD, Casali EA, Leal CA, da Silva JC, Moretto MB, de Pinheiro FV, Morsch VM, Schetinger MR, Leal DB (2010) Activities of enzymes that hydrolyze adenine nucleotides in platelets from patients with rheumatoid arthritis. Clin Biochem 43: 1096-1100.
22. Maldonado PA, Corrêa MC, Becker LV, Flores C, Moretto MB, Morsch V, Schetinger MRC (2008) Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in patients with uterine cervix neoplasia. Clin Biochem 41: 400-406.
23. Bagatini MD, Martins CC, Battisti V, Spanevello RM, Gasparetto D, Rosa CS, Gonçalves JF, Schetinger MR, dos Santos RB, Morsch VM (2008) Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction. Clin Biochem 41: 1181-1185.
24. Leal CA, Schetinger MR, Leal DB, Bauchspiess K, Schrekker CM, Maldonado PA, Morsch VM, da Silva JE (2007) NTPDase and 5′-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis. Mol Cell Biochem 304: 325-330.
25. Anonymous (1985) Meeting of applied research in Chagas disease. Validity of the concept of indeterminate form. Rev Soc Bras Med Trop 18: 46.
26. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of proteins-dye binding. Anal Biochem 72: 248-254.
27. Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157: 375-380.
28. Fürsternau C, da Trentin DS, Barreto-Chaves ML, Sarkis JJ (2006) Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. Platelets 17: 84-91.
29. Sakura H, Nagashima S, Nakashima A, Maeda M (1998) Characterization of fetal serum 5′-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res 91: 83-89.
30. Frassetto SS, Dias RD, Sarkis JJ (1993) Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3. 6. 1. 5) in rat blood platelets. Mol Cell Biochem 129: 47-55.
31. Giusti G, Galanti B (1984) Colorimetric Method. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Verlag Chemie, Weinheim, pp 315-323.
32. Born GVR, Cross MJ (1963) The aggregation of blood platelets. J Physiol 95: 168-178.
33. Añez N, Carrasco H, Parada H, Crisante G, Rojas A, Fuenmayor C, Gonzalez N, Percoco G, Borges R, Guevara P, Ramirez JL (1999) Myocardial parasite persistence in chronic Chagasic patients. AmJTrop Med Hyg 60: 726-732.
34. Lopes ER, Chapadeiro E, Andrade ZA, Almeida H, Rocha A (1981) Pathological anatomy of hearts from asymptomatic Chagas disease patients dying in a violent manner. Mem Inst Oswald Cruz 76: 189-197.
35. Lopes ER, Rocha A, Adad SJ, Fernandes EL, Chapadeiro E (1988) Necroscopic study of a case of chronic form of Chagas disease with electrocardiogram and x-rays of normal thorax. Special reference to the excito-conductor system of the heart. Rev Soc Bras Med Trop 21: 67-70.
36. Cardoso JE, Brener Z (1980) Hematological changes in mice experimentally infected with Trypanosoma cruzi. Mem Inst Oswald Cruz 75: 97-104.
37. Jamra MA, De Freitas JL, Amato Neto V, Da Silva LH, Tartari JT (1954) Hematological aspects of the initial phases of Chagas' disease. Rev Paul Med 45: 544-552.
38. Rossi MA, Gonçalves S, Ribeiro-dos-Santos R (1984) Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis. Am J Pathol 114: 209-216.
39. Tanowitz HB, Burns ER, Sinha AK, Kahn NN, Morris SA, Factor SM, Hatcher VB, Bilezikian JP, Baum SG, Wittner M (1990) Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. AmJTrop Med Hyg 43: 274-281.
40. Gordon EL, Pearson JD, Dickinson ES, Moreau D, Slakey LL (1989) The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface. J Biol Chem 264: 18986-18995.
41. Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, D'Orléans-Juste P, Marceau F, Thorin E, Sévigny J (2010) NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc Res 85: 204-213.
42. Heine P, Braun N, Heilbronn A, Zimmermann H (1999) Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. Eur J Biochem 262: 102-107.
43. Soslau G, Youngprapakorn D (1997) A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta 1355: 131-140.
44. Park HS, Hourani SM (1999) Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5-diphosphate (ADP) in human platelet. Br J Pharmacol 127: 1359-1366.
45. Borowiec A, Lechward K, Tkacz-Stachowska K, Skladanowski AC (2006) Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5′-nucleotidases. Acta Biochim Pol 53: 269-278.
46. Fretes RE, Paglini P, Fernández AR, Enders J, de Fabro SP (1999) Trypanosoma cruzi: increased 5′-nucleotidase activity associated with dysfunction of adrenergic receptors in acutely infected albino Swiss mice. J Parasitol 85: 970-972.
47. Zhai X, Zhou X, Ashraf M (1995) Interaction of singlet oxygen with 5′-nucleotidase in rat hearts. J Mol Cell Cardiol 27: 2453-2464.
48. Headrick JP, Emerson CS, Berr SS, Berne RM, Matherne GP (1996) Interstitial adenosine and cellular metabolism during beta-adrenergic stimulation of the in situ rabbit heart. Cardiovasc Res 31: 699-710.
49. Da Silva AS, Pimentel VC, Fiorenza AM, França RT, Tonin AA, Jaques JA, Leal CA, Da Silva CB, Morsch V, Sschetinger MR, Lopes ST, Monteiro SG (2011) Activity of cholinesterases and adenosine deaminase in blood and serum of rats experimentally infected with Trypanosoma cruzi. Ann Trop Med Parasitol 105: 385-391.
50. Tanowitz HB, Kirchhoff LV, Simon D, Morris SA, Weiss LM, Wittner M (1992) Chagas' disease. Clin Microbiol Rev 5: 400-419.
51. Paul S, Feoktistov I, Hollister AS, Robertson D, Biaggioni I (1990) Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Mol Pharmacol 37: 870-875.
52. Linden MD, Barnard MR, Frelinger AL, Michelson AD, Przyklenk K (2008) Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models. Thromb Res 121: 689-698.
53. Sim DS, Merrill-Skoloff G, Furie BC, Furie B, Flaumenhaft R (2004) Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood 103: 2127-2134.
54. Minamino T, Kitakaze M, Morioka T, Node K, Komamura K, Takeda H, Inoue M, Hori M, Kamada T (1996) Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity. Am J Physiol 270: H238-H244.
55. Kitakaze M, Minamino T, Node K, Komamura K, Hori M (1996) Activation of ecto-5′-nucleotidase and cardioprotection by ischemic preconditioning. Basic Res Cardiol 91(1): 23-26.